330 related articles for article (PubMed ID: 15492268)
1. Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.
Ito H; Duxbury M; Benoit E; Clancy TE; Zinner MJ; Ashley SW; Whang EE
Cancer Res; 2004 Oct; 64(20):7439-46. PubMed ID: 15492268
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.
Ito H; Duxbury M; Benoit E; Farivar RS; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 May; 318(2):594-600. PubMed ID: 15120641
[TBL] [Abstract][Full Text] [Related]
3. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.
Ito H; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE
Surgery; 2003 Aug; 134(2):221-6. PubMed ID: 12947321
[TBL] [Abstract][Full Text] [Related]
5. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
Chiu WT; Shen SC; Chow JM; Lin CW; Shia LT; Chen YC
Neurobiol Dis; 2010 Jan; 37(1):118-29. PubMed ID: 19804834
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via the mitogen-activated protein kinase pathway.
Zhou WH; Du MR; Dong L; Zhu XY; Yang JY; He YY; Li DJ
Hum Reprod; 2007 Oct; 22(10):2743-50. PubMed ID: 17566014
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Lynch CC; Crawford HC; Matrisian LM; McDonnell S
Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells.
Naito S; Shimizu S; Matsuu M; Nakashima M; Nakayama T; Yamashita S; Sekine I
Biochem Biophys Res Commun; 2002 Feb; 291(1):130-8. PubMed ID: 11829472
[TBL] [Abstract][Full Text] [Related]
13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
14. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
15. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
16. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
Liu CY; Lai YY; Lo CJ
J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
[TBL] [Abstract][Full Text] [Related]
17. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
18. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z
Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216
[TBL] [Abstract][Full Text] [Related]
19. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.
Lara-Pezzi E; Gómez-Gaviro MV; Gálvez BG; Mira E; Iñiguez MA; Fresno M; Martínez-A C; Arroyo AG; López-Cabrera M
J Clin Invest; 2002 Dec; 110(12):1831-8. PubMed ID: 12488433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
